AA
CASC

ALPS Advisors’s Cascadian Therapeutics, Inc. CASC Stock Holding History

ALPS Advisors’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-56,018
Closed -$207K – 1043
2017
Q4 		$207K Buy
+56,018
New +$207K ﹤0.01% 818